Rchr
J-GLOBAL ID：201701009449211420
Update date: Sep. 29, 2024
Tomita Yusuke
トミタ ユウスケ | Tomita Yusuke
Affiliation and department：
Research field (1)：
Respiratory medicine
Research keywords (10)：
肺胞蛋白症
, Gut microbiome
, SARSーCoVー2
, COVIDー19
, Pharmacodynamics
, Interstitial pneumonia
, Infectious disease
, Immunology
, Tumor immunology
, Lung Cancer
Research theme for competitive and other funds (3)：
- 2022 - 2027 Development of a new combinational therapy with immune checkpoint blockade and live biotherapeutic products for advanced lung cancer
- 2021 - 2024 Development of irAE management strategy based on immuno-senescence, and novel cancer immunotherapy balancing augmented anti-tumor immunity and decreased risk of adverse events
- 2018 - 2023 進行肺癌を対象とした腫瘍免疫抑制回避と能動免疫を併用するがん免疫療法の臨床研究
Papers (161)：
-
Moriyasu Anai, Hiroki Inoue, Koichi Saruwatari, Seitaro Oda, Shinya Shiraishi, Kimitaka Akaike, Kosuke Imamura, Takayuki Jodai, Shinya Sakata, Shinji Iyama, et al. Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respiratory investigation. 2024. 62. 6. 1072-1078
-
Kimitaka Akaike, Koichi Saruwatari, Shinya Sakata, Seitaro Oda, Shinya Shiraishi, Shinji Iyama, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. 18F-FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on 18F-FDG PET/CT: A case report. Respirology Case Reports. 2024. 12. 7
-
Miki KUROKI, Kimitaka AKAIKE, Seiya NAKASHIMA, Akira TAKAGI, Shinji IYAMA, Aiko MASUNAGA, Yusuke TOMITA, Hidenori ICHIYASU, Takuro SAKAGAMI. Pulmonary Nocardiosis in a Patient with Autoimmune Pulmonary Alveolar Proteinosis that Become Stabilize after Whole-Lung Lavage. Kansenshogaku Zasshi. 2024. 98. 2. 151-155
-
福嶋 一晃, 御任 玲美, 猿渡 功一, 城臺 孝之, 坂田 晋也, 猪山 慎治, 冨田 雄介, 一安 秀範, 坂上 拓郎. 小細胞肺癌に対するアテゾリズマブ併用化学療法とデュルバルマブ併用化学療法の有効性と安全性の比較検討. 日本呼吸器学会誌. 2024. 13. 増刊. 330-330
-
Shohei Hamada, Kei Muramoto, Kimitaka Akaike, Hiroko Okabayashi, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. Scientific Reports. 2024. 14. 1
ｍore...
MISC (77)：
-
Chieko Yoshida, Aiko Masunaga, Sho Saeki, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. Predicting daily physical activity with using 6MWT in patients with chronic interstitial lung diseases. EUROPEAN RESPIRATORY JOURNAL. 2020. 56
-
Kimitaka Akaike, Koichi Saruwatari, Seitaro Oda, Shohei Hamada, Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii, Shinya Shiraishi, Takuro Sakagami. Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease. EUROPEAN RESPIRATORY JOURNAL. 2019. 54
-
猿渡 功一, 冨田 雄介, 佐藤 亮, 佐伯 祥, 一安 秀範, 藤井 一彦, 坂上 拓郎, 高松 孝太郎, 中根 俊成. 無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例. 肺癌. 2019. 59. 3. 299-299
-
猿渡 功一, 冨田 雄介, 佐藤 亮, 佐伯 祥, 一安 秀範, 藤井 一彦, 坂上 拓郎, 高松 孝太郎, 中根 俊成. 無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例. 肺癌. 2019. 59. 3. 299-299
-
御任 玲美, 猿渡 功一, 後藤 由比古, 玉野井 大介, 冨田 雄介, 佐伯 祥, 中村 和芳, 岡本 真一郎, 一安 秀範, 藤井 一彦, et al. 非小細胞肺癌におけるPD-1阻害薬の治療効果に対するステロイドの影響. 日本呼吸器学会誌. 2019. 8. 増刊. 206-206
ｍore...
Patents (7)：
-
GPC-3 epitope peptides for Th1 cells and vaccines containing the same
-
KIF20A epitope peptides for Th1 cells and vaccines containing the same.
-
CDCA1 epitope peptides for Th1 cells and vaccines containing the same
-
LY6K epitope peptides for Th1 cells and vaccines containing the same.
-
IMP-3 epitope peptides for Th1 cells and vaccines containing the same.
ｍore...
Books (7)：
-
消化器疾患と腸内細菌叢の関わり-臨床的意義と治療への影響- 免疫チェックポイント阻害薬治療の有効性とプロバイオティクス
Progress in medicine 2022
-
HLA拘束性T細胞を誘導可能な末梢血モノサイト由来樹状細胞の大量産生法の開発
日本組織適合性学会 2015
-
CTLとTh1細胞を同時に活性化できるがん抗原ペプチドワクチン療法の開発
(株)メディカルレビュー社 2014
-
HLA Revisited HLA多型を考慮したがん免疫療法の開発
(株)医薬ジャーナル社 2013
-
【がんの免疫制御-研究と臨床の最前線】 効果的ながん免疫療法に必要な技術開発とその臨床応用【腫瘍抗原の同定とがんワクチン】 cDNAマイクロアレイ解析とHLAトランスジェニックマウスを利用した理想的な腫瘍抗原ペプチドワクチン療法の開発
医歯薬出版(株) 2013
ｍore...
Lectures and oral presentations (8)：
-
腸内細菌叢を標的とした肺癌の治療戦略
(第92回日本呼吸器学会・日本結核非結核性抗酸菌症学会九州支部春季学術講演会 シンポジウム2 2024)
-
Targeting the gut microbiota to treat advanced lung cancer
(2023)
-
The Importance of Gut Bacteria in Cancer Immunotherapy
(2023)
-
Targeting the gut microbiota to treat advanced lung cancer
(2022)
-
Treatment strategy for lung cancer with ILA: Targeting the gut microbiota to treat advanced lung cancer
(2022)
ｍore...
Professional career (2)：
Awards (3)：
- 2016 - National Institute of Health (NIH) National Institute of Health (NIH) Fellows Award for Research Excellence (FARE) 2016. ♣ Development of a new circulating tumor cell platform and a third generation next-gen sequencing technique for the discovery of oncogenic androgen receptor splice variants driving castrate-resistant prostate cancer
- 2012 - Japanese Society for Histocompatibility and Immunogenetics ♣ Incentive award of The 21st Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics
- 2012 - ♣ Kyusyu branch meeting of the Japanese Respiratory Society ♣ Incentive award of The 69st Kyusyu branch meeting of the Japanese Respiratory Society
Return to Previous Page
